Skip to main content

Table 1 Clinical characteristics of individuals with type 1 diabetes (T1D), type 2 diabetes (T2D), and without diabetes (Control) by the presence of subclinical carotid atherosclerosis

From: Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes

 

Control

T1D

T2D

No plaque

Plaque

P-value

No plaque

Plaque

P-value

No plaque

Plaque

P-value

N = 110

N = 97

N = 78

N = 73

N = 78

N = 77

Sex (Men)

56 (50.9%)

58 (59.8%)

0.253

38 (48.7%)

42 (57.5%)

0.357

40 (51.3%)

46 (59.7%)

0.369

Age (Years)

52.4 (11.9)

57.4 (11.8)

0.003

44.8 (6.78)

52.8 (9.56)

 < 0.001

56.5 (9.05)

62.1 (8.52)

 < 0.001

BMI (kg/m2)

26.3 (3.88)

27.0 (4.05)

0.203

25.7 (4.09)

26.6 (3.88)

0.2

31.5 (5.58)

31.1 (5.37)

0.645

Waist (cm)

95.1 (11.9)

97.5 (11.4)

0.145

89.0 (11.7)

91.9 (12.4)

0.146

105 (12.3)

105 (13.4)

0.901

Former/Current Smoker

47 (42.7%)

52 (53.6%)

0.154

32 (41.0%)

49 (67.1%)

0.002

29 (37.2%)

38 (49.4%)

0.172

sBP (mmHg)

122 (14.9)

128 (14.8)

0.004

127 (17.3)

134 (17.2)

0.011

134 (18.7)

140 (17.0)

0.03

dBP (mmHg)

77.1 (9.46)

78.9 (9.32)

0.184

74.5 (10.1)

73.3 (10.7)

0.49

79.9 (11.3)

79.1 (9.95)

0.664

Hypertension (Yes)

14 (12.7%)

35 (36.1%)

 < 0.001

10 (12.8%)

42 (57.5%)

 < 0.001

37 (47.4%)

52 (67.5%)

0.018

Dyslipidaemia (Yes)

30 (27.3%)

35 (36.1%)

0.225

30 (38.5%)

53 (72.6%)

 < 0.001

38 (48.7%)

42 (54.5%)

0.572

Antiplatelet (Yes)

–

–

–

17 (21.8%)

35 (47.9%)

0.001

19 (24.4%)

24 (31.2%)

0.443

HbA1c (%)

5.45 (0.33)

5.49 (0.40)

0.382

7.53 (0.80)

7.65 (1.00)

0.413

7.78 (1.57)

7.65 (1.79)

0.625

HbA1c IFCC

36.1 (3.76)

36.6 (4.47)

0.428

58.8 (8.71)

60.2 (10.9)

0.406

61.5 (17.1)

60.1 (19.6)

0.627

Triglycerides (mg/dL)

113 (53.0)

109 (50.1)

0.575

68.5 (28.3)

86.4 (54.8)

0.014

136 (80.1)

149 (84.6)

0.303

Total cholesterol (mg/dL)

205 (35.4)

210 (32.3)

0.298

184 (26.4)

178 (31.8)

0.233

185 (38.7)

187 (44.2)

0.777

HDL cholesterol (mg/dL)

57.7 (13.0)

57.9 (14.5)

0.907

66.2 (17.1)

61.5 (15.4)

0.075

49.1 (13.1)

49.2 (13.1)

0.979

LDL cholesterol (mg/dL)

125 (30.1)

131 (29.6)

0.185

104 (20.8)

101 (27.8)

0.461

110 (33.3)

109 (36.4)

0.86

DM duration (years)

–

–

–

22.8 (9.77)

24.5 (11.7)

0.331

6.10 (7.05)

6.68 (8.14)

0.637

Retinopathy (Yes)

–

–

–

32 (41.6%)

41 (56.9%)

0.087

20 (29.4%)

28 (39.4%)

0.287

ALT

22.2 (14.8)

21.5 (19.3)

0.792

18.8 (8.86)

22.8 (10.5)

0.012

32.6 (23.8)

28.9 (14.1)

0.247

  1. Plaque and No plaque columns indicate the individuals with and without atherosclerotic plaques, respectively. The P-value column shows the significance of the association between each clinical variable and the presence of plaque. Statistically significant values are highlighted in bold. BMI, body mass index; sBP, systolic blood pressure; dBP, diastolic blood pressure; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; DM, diabetes mellitus; ALT, alanine aminotransferase levels